Gene Drive patents may be used to force public disclosure of research

Antonio Regalado, 20 October 2016, MIT Technology Review,

MIT biology professor Kevin Esvelt helped develop the CRISPR/Cas9 gene drive and is coauthor on a gene drive patent application.  Esvelt is concerned that gene drive technology developed behind closed doors could lead to a skeptical public slowing the use of the gene drive technology.  In an attempt to prevent this, Esvelt has proposed using his patent rights to force scientists into being 100% open about their gene drive work and requiring safety procedures to prevent escape.  Since patent law states that the holder can stop anyone from making or using the technology, Esvelt may have the legal right to force full disclosure and safety compliance.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply